Skip to content

Screening With Portable X-rays for Rapid Recognition of TB

Mobilizing Innovative Strategies to Improve Tuberculosis (TB) Diagnosis and Retention in the TB Care Cascade for Migrant Communities in New York City

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07737275
Acronym
SPOT-TB
Enrollment
1000
Registered
2026-07-30
Start date
2026-08-15
Completion date
2028-03-10
Last updated
2026-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV (Human Immunodeficiency Virus), Tuberculosis Infection, Latent, Tuberculosis (TB)

Keywords

Tuberculosis, Mobile Screening, Chest x-ray, HIV

Brief summary

SPOT-TB (Screening with Portable X-rays for rapid recOgniTion of TB) is a prospective study evaluating a community-based tuberculosis (TB) screening strategy for migrant populations in New York City. The screening intervention integrates mobile ultra-portable digital chest radiography with artificial intelligence-assisted image interpretation, tuberculosis symptom assessment, latent tuberculosis infection testing, and HIV testing. Participants with concerning screening findings are referred for appropriate clinical evaluation. The study will evaluate the feasibility, acceptability, and effectiveness of this integrated screening strategy for improving early identification of active pulmonary tuberculosis and linkage to care in community settings.

Detailed description

Tuberculosis (TB) remains a major public health challenge in the United States, with increasing numbers of reported cases in recent years. Delayed diagnosis contributes to ongoing transmission and poorer clinical outcomes, particularly among populations facing barriers to healthcare access. Migrant populations in New York City experience a disproportionately high burden of TB infection and disease, highlighting the need for innovative community-based screening strategies. SPOT-TB (Screening with Portable X-rays for rapid recOgniTion of TB) is a prospective study evaluating a novel community-based TB screening strategy. The intervention combines mobile ultra-portable digital chest radiography, artificial intelligence-assisted image interpretation, tuberculosis symptom assessment, latent tuberculosis infection testing, and HIV testing to provide rapid, front-loaded screening while minimizing loss to follow-up. Participants with concerning screening findings are referred for appropriate clinical evaluation according to standard clinical practice. The study will evaluate the feasibility, acceptability, and effectiveness of this integrated screening strategy for improving early identification of active pulmonary tuberculosis, facilitating linkage to care, and informing future community-based TB screening programs. The study will also provide information on TB and latent TB infection prevalence among migrant populations and the implementation of mobile AI-assisted screening in an urban U.S. setting.

Interventions

DIAGNOSTIC_TESTMobile chest radiography for tuberculosis screening

The diagnostic screening includes a digital chest x-ray (includes AI software to interpret x-rays), optional lung ultrasound, oral swab for HIV testing, and a blood draw for TB testing.

Sponsors

Columbia University
Lead SponsorOTHER
National Institute of Allergy and Infectious Diseases (NIAID)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult persons 18 years or older * Self-identifying as migrants to the US * Self-reporting migration within the 24 months

Exclusion criteria

* Lack capacity for informed consent * Unable to perform translation/study materials not available in appropriate language * Unwilling to participate * Prisoner * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Completion of Appropriate Clinical ReferralsUp to 12 weeks post-visitProportion of participants who complete recommended diagnostic evaluations and clinical referrals, stratified by tuberculosis risk screening group.

Contacts

CONTACTAllison Wolf, MPH
aw2565@cumc.columbia.edu212-342-44'1

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 31, 2026